Real-time enrollment status for this castration resistant metastatic prostate cancer clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 12:21 PM UTC
| NCT Number | NCT07581184 |
| Recruiting Status | Recruiting |
| Condition | Castration Resistant Metastatic Prostate Cancer |
| Phase | PHASE1 |
| Target Enrollment | 138 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Aktis Oncology, Inc. |
| Last Updated on CT.gov | July 14, 2026 (Jul 14, 2026) |
As of August 28, 2026: Clinical trial NCT07581184 is currently recruiting participants. This phase1 study for castration resistant metastatic prostate cancer is actively seeking new participants at 4 locations across the United States. The study is sponsored by Aktis Oncology, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07581184 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07581184 was last updated Jul 14, 2026 (July 14, 2026). HelloStudys verifies this status automatically.